Immune Therapy Combinations for Melanoma Tumors Resistant to PD-1 Inhibitors & New Initiatives to Overcome Resistance to Immune Checkpoint Inhibitors
By
Yale Cancer Center
FEATURING
Harriet Kluger
By
Yale Cancer Center
FEATURING
Harriet Kluger
Login to view comments.
Click here to Login